Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16252081
[patent_doc_number] => 20200261455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES
[patent_app_type] => utility
[patent_app_number] => 16/757072
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757072 | INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES | Oct 17, 2018 | Abandoned |
Array
(
[id] => 13929035
[patent_doc_number] => 20190048033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/164632
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 859
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164632
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/164632 | Ether compounds for treatment of complement mediated disorders | Oct 17, 2018 | Issued |
Array
(
[id] => 17236609
[patent_doc_number] => 11180480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Synthesis of 4-aminopyrimidine compounds
[patent_app_type] => utility
[patent_app_number] => 16/757008
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7880
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757008
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757008 | Synthesis of 4-aminopyrimidine compounds | Oct 16, 2018 | Issued |
Array
(
[id] => 16908022
[patent_doc_number] => 11040039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Treatment of inflammatory disorders
[patent_app_type] => utility
[patent_app_number] => 16/157069
[patent_app_country] => US
[patent_app_date] => 2018-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 37420
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157069
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157069 | Treatment of inflammatory disorders | Oct 9, 2018 | Issued |
Array
(
[id] => 17162952
[patent_doc_number] => 11149039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Process for preparing spiro derivatives
[patent_app_type] => utility
[patent_app_number] => 16/754044
[patent_app_country] => US
[patent_app_date] => 2018-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7191
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754044 | Process for preparing spiro derivatives | Oct 9, 2018 | Issued |
Array
(
[id] => 18369058
[patent_doc_number] => 11649212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
[patent_app_type] => utility
[patent_app_number] => 16/754171
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21231
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754171 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | Oct 7, 2018 | Issued |
Array
(
[id] => 13867381
[patent_doc_number] => 20190030031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => GALACTOKINASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF ASSOCIATED DISEASES AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/152735
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16152735
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/152735 | Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders | Oct 4, 2018 | Issued |
Array
(
[id] => 15634319
[patent_doc_number] => 10590136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
[patent_app_type] => utility
[patent_app_number] => 16/150345
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5813
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150345
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150345 | Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Oct 2, 2018 | Issued |
Array
(
[id] => 16312240
[patent_doc_number] => 20200290978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/651256
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -121
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651256 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Sep 25, 2018 | Abandoned |
Array
(
[id] => 17680965
[patent_doc_number] => 11365204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/648263
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20392
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648263 | Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | Sep 19, 2018 | Issued |
Array
(
[id] => 14774881
[patent_doc_number] => 20190262338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/137241
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/137241 | PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS | Sep 19, 2018 | Abandoned |
Array
(
[id] => 13901627
[patent_doc_number] => 20190040018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => HOMOPIPERAZINE-BASED CATALYSTS FOR NEUTRALIZATION OF ORGANOPHOSPHORUS-BASED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/136057
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16136057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/136057 | Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds | Sep 18, 2018 | Issued |
Array
(
[id] => 13928899
[patent_doc_number] => 20190047965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => ECO-FRIENDLY MATERIALS AND METHODS FOR RENEWABLE AND SUSTAINABLE APPLICATIONS IN MATERIAL CHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 16/124418
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/124418 | Eco-friendly materials and methods for renewable and sustainable applications in material chemistry | Sep 6, 2018 | Issued |
Array
(
[id] => 13774621
[patent_doc_number] => 20190000849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => NOVEL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/125148
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/125148 | Compounds | Sep 6, 2018 | Issued |
Array
(
[id] => 15634273
[patent_doc_number] => 10590113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
[patent_app_type] => utility
[patent_app_number] => 16/122975
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53551
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122975 | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists | Sep 5, 2018 | Issued |
Array
(
[id] => 18117503
[patent_doc_number] => 11548884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Cyclic amidine compounds for the treatment of autoimmune disease
[patent_app_type] => utility
[patent_app_number] => 17/274040
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8999
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274040 | Cyclic amidine compounds for the treatment of autoimmune disease | Sep 5, 2018 | Issued |
Array
(
[id] => 16253453
[patent_doc_number] => 20200262827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => AROMATIC DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICAL APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/644919
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644919 | Aromatic derivative, preparation method for same, and medical applications thereof | Sep 3, 2018 | Issued |
Array
(
[id] => 14639051
[patent_doc_number] => 10364258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Heteroaryl inhibitors of PDE4
[patent_app_type] => utility
[patent_app_number] => 16/111700
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92366
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16111700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/111700 | Heteroaryl inhibitors of PDE4 | Aug 23, 2018 | Issued |
Array
(
[id] => 17393326
[patent_doc_number] => 11242326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Multivalent ligand for myotonic dystrophy
[patent_app_type] => utility
[patent_app_number] => 16/641450
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 11458
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641450 | Multivalent ligand for myotonic dystrophy | Aug 22, 2018 | Issued |
Array
(
[id] => 16108405
[patent_doc_number] => 20200206225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => PYRUVATE KINASE MODULATORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/639086
[patent_app_country] => US
[patent_app_date] => 2018-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639086 | Pyruvate kinase modulators and use thereof | Aug 14, 2018 | Issued |